Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, J. G.
Right arrow Articles by Phillips, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, J. G.
Right arrow Articles by Phillips, W. T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 17, Issue 4 255-262, Copyright © 1994 by American Diabetes Association


ARTICLES

Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients

JG Schwartz, D Guan, GM Green and WT Phillips
Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750.

OBJECTIVE--To determine whether an oral trypsin/chymotrypsin inhibitor, POT II, will delay the rate of gastric emptying in recently diagnosed type II diabetic patients and improve their postprandial metabolic parameters. RESEARCH DESIGN AND METHODS--Two gastric emptying studies were performed on each of six type II diabetic patients. During one study, the patient ingested a glucose/protein solution, and during the other study, the patient ingested the same glucose/protein solution with the addition of 1.5 g of POT II, a putative stimulant of cholecystokinin (CCK) release. Each patient served as their own control subject. Each of the two oral solutions were administered to the patients in a counter-balanced order separated by at least 1 week. RESULTS--Serum insulin, plasma glucose, plasma gastric inhibitory polypeptide (GIP) values, and the rate of gastric emptying were all significantly (P < 0.05) decreased over the 2-h testing period when POT II was added to the oral glucose/protein meal. The area under the curve above baseline for glucose with POT II was 75% of the glucose value without POT II. The area under the curve above baseline for insulin with POT II was 68% of the value without POT II. Plasma CCK was significantly increased by POT II 15 min postprandially. CONCLUSIONS--A trypsin/chymotrypsin inhibitor, POT II, can delay the rate of gastric emptying, and decrease postprandial plasma glucose levels, GIP levels, and serum insulin levels in type II diabetic patients diagnosed recently. Delay of gastric emptying in diabetic patients may provide a unique or adjunctive approach to the treatment of type II diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Gentilcore, R. Chaikomin, K. L. Jones, A. Russo, C. Feinle-Bisset, J. M. Wishart, C. K. Rayner, and M. Horowitz
Effects of Fat on Gastric Emptying of and the Glycemic, Insulin, and Incretin Responses to a Carbohydrate Meal in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2062 - 2067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Chaikomin, S. Doran, K. L. Jones, C. Feinle-Bisset, D. O'Donovan, C. K. Rayner, and M. Horowitz
Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects
Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E504 - E507.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. J. Meier, G. Kemmeries, J. J. Holst, and M. A. Nauck
Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects
Diabetes, July 1, 2005; 54(7): 2212 - 2218.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. G. O'Donovan, S. Doran, C. Feinle-Bisset, K. L. Jones, J. H. Meyer, J. M. Wishart, H. A. Morris, and M. Horowitz
Effect of Variations in Small Intestinal Glucose Delivery on Plasma Glucose, Insulin, and Incretin Hormones in Healthy Subjects and Type 2 Diabetes
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3431 - 3435.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. O. Schneeman, B. Burton-Freeman, and P. Davis
Incorporating Dairy Foods into Low and High Fat Diets Increases the Postprandial Cholecystokinin Response in Men and Women
J. Nutr., December 1, 2003; 133(12): 4124 - 4128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Burton-Freeman, P. A Davis, and B. O Schneeman
Plasma cholecystokinin is associated with subjective measures of satiety in women
Am. J. Clinical Nutrition, September 1, 2002; 76(3): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Bourdon, B. Olson, R. Backus, B. D. Richter, P. A. Davis, and B. O. Schneeman
Beans, as a Source of Dietary Fiber, Increase Cholecystokinin and Apolipoprotein B48 Response to Test Meals in Men
J. Nutr., May 1, 2001; 131(5): 1485 - 1490.
[Abstract] [Full Text]


Home page
Diabetes CareHome page
C. K. Rayner, M. Samsom, K. L. Jones, and M. Horowitz
Relationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Diabetes Care, February 1, 2001; 24(2): 371 - 381.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.